ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer

Jiang, Yuming*; Xie, Jingjing; Huang, Weicai; Chen, Hao; Xi, Sujuan; Han, Zhen; Huang, Lei; Lin, Tian; Zhao, Li-Ying; Hu, Yan-Feng; Yu, Jiang; Cai, Shi-Rong*; Li, Tuanjie*; Li, Guoxin*南方医科大学; 中山大学
Cancer Immunology Research2019-12DOI: 10.1158/2326-6066.CIR-19-0311
81被引2阅读
引用收藏
分享

摘要

Current gastric cancer staging alone cannot predict prognosis and adjuvant chemotherapy benefits in stage II and III gastric cancer. Tumor immune microenvironment biomarkers and tumor-cell chemosensitivity might add predictive value to staging. This study aimed to construct a predictive signature integrating tumor immune microenvironment and chemosensitivity-related features to improve the prediction of survival and adjuvant chemotherapy benefits in patients with stage II to III gastric cancer. We used IHC to assess 26 features related to tumor, stroma, and chemosensitivity in tumors from 223 patients and evaluated the association of the features with disease-free survival (DFS) and overall survival (OS). Support vector machine (SVM)-based methods were used to develop the predictive signature, which we call the SVM signature. Validation of the signature was performed in two independent cohorts of 445 patients. The diagnostic signature integrated seven features: CD3(+) cells at the invasive margin (CD3 IM), CD8(+) cells at the IM (CD8 IM), CD45RO(+) cells in the center of tumors (CD45RO CT), CD66b(+) cells at the IM (CD66b IM), CD34(+) cells, periostin, and cyclooxygenase-2. Patients fell into low- and high-SVM groups with significant differences in 5-year DFS andOSin the training and validation cohorts (all P < 0.001). The signature was an independent prognosis indicator in multivariate analysis in each cohort. The signature had better prognostic value than various clinicopathologic risk factors and single features. High-SVM patients exhibited a favorable response to adjuvant chemotherapy. Thus, this SVM signature predicted survival and has the potential for identifying patients with stage II and III gastric cancer who could benefit from adjuvant chemotherapy.

学科与关键词

关键词
SUPPORT VECTOR MACHINESADJUVANT CAPECITABINECOLORECTAL-CANCERLIVER METASTASESSTROMAL CELLSOPEN-LABELCLASSIFICATIONANGIOGENESISOXALIPLATINCARCINOMA
相关
加载中…
  • An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts
    Li, Xunjun; Zhai, Zhongya; Ding, Wenfu; Chen, Li; Zhao, Yuyun; Xiong, Wenjun; Zhang, Yunfei; Lin, Dingyi; Chen, Zequn; Wang, Wei; Gao, Yongshun; Cai, Shirong; Yu, Jiang; Zhang, Xinhua*; Liu, Hao*; Li, Guoxin; Chen, Tao*International Journal of Surgery, 2022, 105: 106889.被引 6
  • Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer
    Jiang, Yuming; Jin, Cheng; Yu, Heng; Wu, Jia; Chen, Chuanli; Yuan, Qingyu; Huang, Weicai; Hu, Yanfeng; Xu, Yikai; Zhou, Zhiwei*; Fisher, George A., Jr.; Li, Guoxin*; Li, Ruijiang*Annals of Surgery, 2021, 274(6): E1153-E1161.被引 108
  • Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
    Chen, Dexin; Chen, Hao; Chi, Liangjie; Fu, Meiting; Wang, Guangxing; Wu, Zhida; Xu, Shuoyu; Sun, Caihong; Xu, Xueqin; Lin, Liyan; Cheng, Jiaxin; Jiang, Wei; Dong, Xiaoyu; Lu, Jianping; Zheng, Jixiang; Chen, Gang; Li, Guoxin; Zhuo, Shuangmu*; Yan, Jun*JAMA Network Open, 2021, 4(11): e2136388.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Immunology Research
发表日期
2019-12
卷期
第 7 卷, 第 12 期
页码
2065-2073
DOI
10.1158/2326-6066.CIR-19-0311
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81872013, 81672446, 81600510]; National Key Research and Development Program of China [2017YFC0108300]; Key Clinical Specialty Discipline Construction Program; Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2018J007]; Director's Foundation of Nanfang Hospital [2016B010]

作者

  • J

    Jiang, Yuming (通讯) (第一作者)

  • X

    Xie, Jingjing

    southern med univ

查看全部 14 位作者收起作者
  • H

    Huang, Weicai

    southern med univ

  • C

    Chen, Hao

    southern med univ

  • X

    Xi, Sujuan

    sun yat sen univ

  • H

    Han, Zhen

    southern med univ

  • H

    Huang, Lei

  • L

    Lin, Tian

    southern med univ

  • Z

    Zhao, Li-Ying

    southern med univ

  • H

    Hu, Yan-Feng

    southern med univ

  • Y

    Yu, Jiang

  • C

    Cai, Shi-Rong (通讯)

    sun yat sen univ

  • L

    Li, Tuanjie (通讯)

    southern med univ

  • L

    Li, Guoxin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417